Routine testing clopidogrel responsive genes combine to platelet aggregation inhibit rate for determination of the drug selection and prognosis of the patient with coronary heart disease after PCI
coronary heart disease、drug selection、determination of
R5 ;R54
2016-01-18(万方平台首次上网日期,不代表论文的发表时间)
共1页
282-282